Patricia Adams-Graves
Hematology & Oncology · Memphis, TNNPI 1578529202
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $133,189 of the $168,159 with a category attached, or 79.2%. 8 manufacturers reported payments, led by Novartis at 50.4% of the total. Reporting peaked in 2019 at $85,491 and has fallen 69.1% since, to $26,400 in 2024. Among hematology & oncology clinicians in TN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 150 payments — averaging $1121.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$85K
- Global Blood Therapeutics, Inc.$44K
- Pfizer$32K
- Bristol Myers Squibb$6K
- Emmaus Medical, Inc.$179
- Novo Nordisk$175
- plus $162 from 2 others
Across 28 payments — averaging $1540.89 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Agios Pharmaceuticals, Inc.$43K
What the payments were for
- Consulting fees$8,9855%
- Speaking & faculty fees$133,18979%
- Travel & lodging$23,52214%
- Food & beverage$2,4631%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 72 | $84,805 |
| Global Blood Therapeutics, Inc. | 30 | $44,133 |
| Pfizer | 31 | $32,310 |
| Bristol Myers Squibb | 4 | $6,394 |
| Emmaus Medical, Inc. | 9 | $179 |
| Novo Nordisk | 2 | $175 |
| Abbott | 1 | $144 |
| KCI USA, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OXBRYTA$69,326
- ADAKVEO$16,344
- Luspatercept$6,309
- FreeStyle Libre$144
- RYBELSUS$113
- NURTEC ODT$100
How this compares
$168,159 in reported general payments places this provider in the 90th percentile of 251 hematology & oncology providers in Tennessee.
Other hematology & oncology in Memphis
- Ugochi OguMemphis$250K
- Donald GravenorMemphis$166K
- Aleksandar JankovMemphis$163K
- Brion RandolphMemphis$162K
- Kenneth AtagaMemphis$157K
- Raymond OsarogiagbonMemphis$117K
- Saurin ChokshiMemphis$86K
- Clyde JonesMemphis$54K
- Salil GoorhaMemphis$51K
- Muhammad RazaMemphis$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.